Certificate Course in Pharmaceutical Market Access
- Descrição
- Currículo
- FAQ
- Revisões
Embark on an enlightening adventure into the pivotal world of Pharmaceutical Market Access, a crucial domain pivotal to the advancement of healthcare and patient well-being. This detailed and expansive course delves deep into the core aspects of Health Technology Assessment (HTA), Real World Evidence (RWE), Health Economics and Outcomes Research (HEOR), Patient Access, Innovation, and Early Access, uncovering the layers and complexities involved in bringing revolutionary medical treatments from conception to the hands of those in need.
With a curriculum designed for both seasoned professionals and newcomers eager to leave their mark in the pharmaceutical sector, this course offers a rare glimpse into the strategic and operational facets of market access. You will be equipped with the knowledge to not only understand but also influence the multifaceted decision-making processes that determine the success and reach of new healthcare solutions.
Through a blend of theoretical knowledge and practical insights, gain the expertise to navigate the regulatory landscapes, understand the economic impact, and advocate for patient access to essential medications. Learn from industry experts and case studies that bring to life the challenges and triumphs of ensuring that groundbreaking therapies are available, affordable, and attainable for patients around the globe.
This course is your gateway to becoming a key player in the pharmaceutical industry, where you’ll be empowered to drive innovation, influence healthcare policy, and contribute to the shaping of future medical breakthroughs. By enrolling, you’re not just signing up for a course; you’re stepping into a community dedicated to making a lasting impact on global health. Your journey towards mastering Pharmaceutical Market Access starts here. Seize this opportunity to be at the forefront of healthcare evolution, and play a part in delivering hope and healing to millions worldwide.
-
2HTA SlidesTexto
-
3HTA Lecture NotesTexto
-
4HTA introductionVídeo Aula
-
5Decoding HTA: They key to pharmaceutical market accessVídeo Aula
-
6Decoding global HTA practicesVídeo Aula
-
7Stakeholder engagement: The heart of HTAVídeo Aula
-
8Mastering HTA: A strategy for market accessVídeo Aula
-
9HTA MasterClassVídeo Aula
-
10Additional Learning materialsTexto
After watch the videos, please continue with the PowerPoint presentation and the core material PDF document.
-
11HEOR SlidesTexto
-
12HEOR Lecture NotesTexto
-
13HEOR: The backbone of healthcare decision makingVídeo Aula
-
14Decoding Health EconomicsVídeo Aula
-
15Fundamentals of outcomes researchVídeo Aula
-
16Data sources and methodologies in HEORVídeo Aula
-
17The power of HEOR modellingVídeo Aula
-
18PROs: The patient´s voiceVídeo Aula
-
19HEOR as game changer in drug developmentVídeo Aula
-
20HEOR: A regulatory and payer perspectiveVídeo Aula
-
21HEOR MasterClassVídeo Aula
-
22Additional Learning materialsTexto
-
23RWE SlidesTexto
-
24RWE Lectures NotesTexto
-
25RWE, a transformative approach in healthcareVídeo Aula
-
26Sources of RWEVídeo Aula
-
27Regulatory framework for RWEVídeo Aula
-
28RWE in drug development and market accessVídeo Aula
-
29Methodologies and techniques in RWEVídeo Aula
-
30Challenges of RWEVídeo Aula
-
31RWE MasterClassVídeo Aula
-
32Additional Learning materialsTexto
After watch the videos, please continue with the PowerPoint presentation and the core material PDF document.
-
33Patient Access SlidesTexto
-
34Patient Access Lecture NotesTexto
-
35Unlocking patient accessVídeo Aula
-
36Barriers to patient accessVídeo Aula
-
37The power of patient advocacyVídeo Aula
-
38Patient access schemesVídeo Aula
-
39Regulatory framework for patient accessVídeo Aula
-
40Stakeholder engagement for improved patient accessVídeo Aula
-
41Learning materialsTexto
